Skip to main content

Peer Review reports

From: Randomized double-blind clinical trial comparing safety and efficacy of the biosimilar BCD-022 with reference trastuzumab

Original Submission
12 Mar 2019 Submitted Original manuscript
19 Jul 2019 Reviewed Reviewer Report - Stefania Gori
17 Nov 2019 Reviewed Reviewer Report - Christian Jackisch
10 Jan 2020 Reviewed Reviewer Report - Research Square Reviewer 1
25 Feb 2020 Author responded Author comments - Sergey Alexeev
Resubmission - Version 2
25 Feb 2020 Submitted Manuscript version 2
2 Jul 2020 Author responded Author comments - Sergey Alexeev
Resubmission - Version 3
2 Jul 2020 Submitted Manuscript version 3
31 Jul 2020 Author responded Author comments - Sergey M. Alexeev
Resubmission - Version 4
31 Jul 2020 Submitted Manuscript version 4
Publishing
3 Aug 2020 Editorially accepted
20 Aug 2020 Article published 10.1186/s12885-020-07247-9

You can find further information about peer review here.

Back to article page